(Q50560002)

15 March 2018

http://europepmc.org/abstract/MED/24132874

title

Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer. (English)

1 reference

15 March 2018

http://europepmc.org/abstract/MED/24132874

main subject

peripheral neuropathy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

L Eckhoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

M-B Jensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

B Ejlertsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

M Ewertz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

17 October 2013

1 reference

15 March 2018

http://europepmc.org/abstract/MED/24132874

published in

Breast Cancer Research and Treatment

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

109-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24132874%20AND%20SRC:MED&resulttype=core&format=json

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Chemotherapy-induced peripheral neurotoxicity (CIPN): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Background noise: the experience of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Toxic neuropathy in patients with pre-existing neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

TAXTOX - a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Peripheral neurotoxicity induced by docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Peripheral neuropathy induced by microtubule-stabilizing agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Peripheral neuropathy secondary to docetaxel (Taxotere)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Assessing health-related quality of life in palliative care: comparing patient and physician assessments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2728-2